Best Agrolife Limited (539660) Earnings Call Transcripts
Best Agrolife Limited's Latest Earnings Call - Q4 FY2026
In Q4 and FY '26, Best Agrolife Limited reported a significant decline in revenue and profitability, with consolidated revenue from operations at INR 257 crores, down 31% YoY, and a net profit of INR 9 crores compared to INR 70 crores in FY '25. The company faced challenges from adverse weather conditions and elevated inventory levels, leading to a 43% decline in Q4 revenue to INR 156 crores. Management indicated that pricing interventions and a focus on patented products would support recovery in FY '27, although no specific revenue guidance was provided.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | INR 257 crores (miss) |
| Gross Margin | 30% (beat) |
| EBITDA | INR 100 crores (miss) |
| Net Profit | INR 9 crores (miss) |
| Q4 Revenue | INR 156 crores (miss) |
| EBITDA Margin | -17% (miss) |
Guidance from management
Management did not provide specific revenue guidance for FY '27 but expressed optimism for a better year, citing ongoing efforts to improve profitability and operational efficiency.
What management said
Yes. So most part of it is coming from our own manufacturing because as we said, the more we are going into patented products, the portfolio of patent product is going. So presently, our patent product portfolio has gone up from 30% to 40% of our [indiscernible] which almost -- entire formulation, everything is done in our own factory. So as of today, almost between 60% to 65% of our sales are being produced in our o...
B2B, just to clarify, B2B is not [indiscernible] because we have a technical manufacturing plant and information manufacturing plant. We do import and do value addition before selling to other B2B players. So those are not necessarily pure trading, but pure trading would be less than 10% of our dealers.
What analysts pressed on
Analysts expressed concerns over the company's ability to meet guidance after significant losses in Q4. There were worries about high receivables and the potential need for capital raising to strengthen the balance sheet.
Main topics on the call
- Revenue Decline — Best Agrolife reported a consolidated revenue of INR 257 crores for FY '26, reflecting a 31% decline YoY. Management attributed this drop to 'unexpected and adverse weather conditions' and a buildup in trade inventory.
- Gross Margin Improvement — Despite revenue declines, gross margin percentage improved to 30% from 29% in FY '25, supported by 'product mix improvement and calibrated pricing actions'.
- Patented Product Growth — Patented products now contribute 40% of total branded sales, up from 30% last year, indicating a shift towards higher-margin offerings. Management noted that 'the patented portfolio went down by only 7%', showing resilie...
- Operational Challenges — The company faced operational headwinds with elevated inventory levels and volatility in raw material prices, leading to a negative EBITDA of INR 27 crores in Q4. Management emphasized a focus on 'operational discipline,...
Read the full Best Agrolife Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Best Agrolife Limited
Best Agrolife Limited (539660) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 4 calls on record spanning February 17, 2025 to July 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 4 Best Agrolife Limited earnings call transcripts on record, spanning February 17, 2025 to July 31, 2026. Based on this history, Best Agrolife Limited reports semi-annually. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.
| Quarter | Date | |
|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | Read transcript → |
| Q4 FY2026 | May 28, 2026 | Read transcript → |
| Q3 FY2026 | Feb 9, 2026 | Read transcript → |
| Q3 FY2025 | Feb 17, 2025 | Read transcript → |